Clemens Höbaus (Clemens Hoebaus)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Low Density Lipoprotein

Cardiovascular Disease

Extracellular Matrix

Top Venues

Vascular medicine (London, England)

Thrombosis and haemostasis

Diabetes & vascular disease research

This page only lists publications with an associated author ORCID identifier.

Publications

Bernhard Zierfuss, Anna Karlinger, Marija Bojic, Renate Koppensteiner, Gerit-Holger Schernthaner, Clemens Höbaus
Urinary vanin-1 as a novel biomarker for survival in peripheral artery disease. Vascular medicine (London, England) 29 (4) (2024)
Gerfried Pesau, Bernhard Zierfuss, Clemens Höbaus, Renate Koppensteiner, Gerit-Holger Schernthaner
Letter: Answer to "Trefoil Factor-3 and Peripheral Artery Disease: Reason or Result". Angiology (2024)
Bernhard Zierfuss, Anna Karlinger, Marija Bojic, Renate Koppensteiner, Gerit-Holger Schernthaner, Clemens Höbaus
Urinary vanin-1 as a novel biomarker for survival in peripheral artery disease. Vascular medicine (London, England) 29 (4) (2024)
Gerfried Pesau, Bernhard Zierfuss, Clemens Höbaus, Renate Koppensteiner, Gerit-Holger Schernthaner
Serum Trefoil Factor-3 Predicts Survival in Peripheral Artery Disease. Angiology (2024)
Bernhard Zierfuss, Anna Karlinger, Marija Bojic, Renate Koppensteiner, Gerit-Holger Schernthaner, Clemens Höbaus
Urinary vanin-1 as a novel biomarker for survival in peripheral artery disease. Vascular medicine (London, England) 29 (4) (2024)
Bernhard Zierfuss, Anna Karlinger, Marija Bojic, Renate Koppensteiner, Gerit-Holger Schernthaner, Clemens Höbaus
Urinary vanin-1 as a novel biomarker for survival in peripheral artery disease. Vascular medicine (London, England) (2024)
Bernhard Zierfuss, Clemens Höbaus, Carsten T Herz, Renate Koppensteiner, Herbert Stangl, Gerit-Holger Schernthaner
High-Density Lipoprotein Particle Subclasses in Statin-Treated Patients with Peripheral Artery Disease Predict Long-Term Survival. Thrombosis and haemostasis 122 (10) (2022)
Clemens Höbaus, Gerfried Pesau, Bernhard Zierfuss, Renate Koppensteiner, Gerit-Holger Schernthaner
Angiogenin-A Proposed Biomarker for Cardiovascular Disease-Is Not Associated With Long-Term Survival in Patients With Peripheral Artery Disease. Angiology 72 (9) (2021)
Marija Bojic, Bernhard Bielesz, Daniel Cejka, Gerit-Holger Schernthaner, Clemens Höbaus
Calcification Propensity in Serum and Cardiovascular Outcome in Peripheral Artery Disease. Thrombosis and haemostasis (2021)
Clemens Höbaus, Martin Ursli, Sarah Mohammed Yussef, Thomas Wrba, Renate Koppensteiner, Gerit-Holger Schernthaner
Soluble urokinase-type plasminogen activator receptor predicts peripheral artery disease severity and outcomes. Vascular medicine (London, England) 26 (1) (2021)
Lavinia Costas, Carsten Thilo Herz, Clemens Höbaus, Renate Koppensteiner, Gerit-Holger Schernthaner
Vascular peroxidase 1 is independently associated with worse kidney function in patients with peripheral artery disease. Journal of nephrology 34 (1) (2020)
Clemens Höbaus, Carsten Thilo Herz, Thomas Wrba, Renate Koppensteiner, Gerit-Holger Schernthaner
Peripheral arterial disease and type 2 diabetes: Older patients still exhibit a survival benefit from glucose control. Diabetes & vascular disease research 17 (2) (2020)
Bernhard Zierfuss, Clemens Höbaus, Carsten Thilo Herz, Gerfried Pesau, Renate Koppensteiner, Gerit-Holger Schernthaner
Thrombospondin-4 increases with the severity of peripheral arterial disease and is associated with diabetes. Heart and vessels 35 (1) (2019)